Research graph
References from Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA , and Serum M‐Protein in Relapsed/Refractory Multiple Myeloma. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s1470-2045(16)30206-6
10.1016/s1470-2045(16)30206-6 · External reference
10.1038/s41408-021-00408-4
10.1038/s41408-021-00408-4 · External reference
10.1111/cts.12836
10.1111/cts.12836 · External reference
10.1158/1535-7163.mct-21-0035
10.1158/1535-7163.mct-21-0035 · External reference
10.1038/s41375-020-0734-z
10.1038/s41375-020-0734-z · External reference
10.1182/blood.2024026028
10.1182/blood.2024026028 · External reference
10.1182/blood-2024-211840
10.1182/blood-2024-211840 · External reference
10.3324/haematol.2016.150896
10.3324/haematol.2016.150896 · External reference
10.2217/imt.15.77
10.2217/imt.15.77 · External reference
10.1016/s2352-3026(23)00243-0
10.1016/s2352-3026(23)00243-0 · External reference
10.1016/s1470-2045(19)30788-0
10.1016/s1470-2045(19)30788-0 · External reference
10.2217/fon-2020-1269
10.2217/fon-2020-1269 · External reference
10.1016/s1470-2045(18)30576-x
10.1016/s1470-2045(18)30576-x · External reference
10.1056/nejmoa2403407
10.1056/nejmoa2403407 · External reference
10.1056/nejmoa2405090
10.1056/nejmoa2405090 · External reference
10.1182/blood-2024-200336
10.1182/blood-2024-200336 · External reference
10.1038/s41408-019-0196-6
10.1038/s41408-019-0196-6 · External reference
10.1002/cncr.34987
10.1002/cncr.34987 · External reference
10.1182/blood-2019-129879
10.1182/blood-2019-129879 · External reference
10.1016/s2152-2650(21)02339-9
10.1016/s2152-2650(21)02339-9 · External reference
10.1200/jco.2022.40.16_suppl.8019
10.1200/jco.2022.40.16_suppl.8019 · External reference
P913: Low‐Dose Belantamab Mafodotin (Belamaf) in Combination With Nirogacestat vs Belamaf Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 DREAMM‐5 Platform Sub‐Study 3
2023 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1182/blood-2023-178026
10.1182/blood-2023-178026 · External reference
10.1002/psp4.12660
10.1002/psp4.12660 · External reference
10.1002/psp4.13016
10.1002/psp4.13016 · External reference
10.1007/s40262-025-01508-1
10.1007/s40262-025-01508-1 · External reference
10.1098/rsif.2019.0722
10.1098/rsif.2019.0722 · External reference
10.3390/cancers13081872
10.3390/cancers13081872 · External reference
10.18637/jss.v045.i03
10.18637/jss.v045.i03 · External reference
10.1002/psp4.41
10.1002/psp4.41 · External reference
10.1007/s11523-023-00989-z
10.1007/s11523-023-00989-z · External reference
10.3389/fphar.2022.803693
10.3389/fphar.2022.803693 · External reference
10.1002/psp4.12815
10.1002/psp4.12815 · External reference
10.1182/blood-2024-198720
10.1182/blood-2024-198720 · External reference
10.1002/cpt.2409
10.1002/cpt.2409 · External reference
10.1007/s11523-025-01174-0
10.1007/s11523-025-01174-0 · External reference
10.1208/s12248-023-00788-4
10.1208/s12248-023-00788-4 · External reference
10.1002/cpt.3663
10.1002/cpt.3663 · External reference
10.1023/b:jopa.0000012999.36063.4e
10.1023/b:jopa.0000012999.36063.4e · External reference
Unresolved reference
External reference
10.1097/01.hs9.0000970836.36618.0e
10.1097/01.hs9.0000970836.36618.0e · External reference
